Using Systane COMPLETE to improve dry eye symptoms before and after cataract surgery
Official title: Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Run by National Taiwan University Hospital · NCT06886373 · Data updated 2026-11-12
This study is testing if using Systane COMPLETE eye drops can help people with dry eyes feel better before and after cataract surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 20 Years to 85 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | March 25, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06886373 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include cataract patients aged 20 to 85 years who have normal cognitive function and are willing to undergo phacoemulsification and intraocular lens implantation.
✕Probably not a fit
Patients with ocular trauma, previous ocular surgery in the planned surgical eye, active ocular infections, or significant abnormalities in the ocular surface may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effects of Systane COMPLETE, a lipid-containing nano-emulsion artificial tear, on patients with dry eye undergoing cataract surgery. It compares corneal astigmatism data before and after the use of Systane COMPLETE to assess its impact on postoperative residual astigmatism. Additionally, the study measures preoperative and postoperative Ocular Surface Disease Index (OSDI) scores and Non-Invasive Tear Break-Up Time (NITBUT) to determine the effectiveness of the treatment in alleviating dry eye symptoms. The goal is to address the challenges posed by dry eye on surgical outcomes and patient comfort.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative discomfort and improve surgical outcomes for cataract patients with dry eye.
How similar studies have gone: While the use of artificial tears in cataract surgery is common, this specific approach with Systane COMPLETE is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (Experimental group ): Cataract patients who participated in the "Optimizing the Ocular Surface with Systane COMPLETE in Patients with Dry Eye Planning for Cataract Surgery" trial (Research Ethics Committee Approval Number: 202311109MIPD) and did not withdraw from the trial midway. Exclusion Criteria (Experimental group ): Patients unwilling to participate in this trial after surgery. Inclusion Criteria(Control group): * Cataract patients aged between 20 and 85 years. * Patients with normal cognitive function who are able to complete the dry eye questionnaire (with - responses recorded by the research team) and are willing to undergo phacoemulsification and intraocular lens implantation under topical anesthesia. Exclusion Criteria (Control group): * Unable to answer the questions in the dry eye survey. * Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts. * Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect. * Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin. * Using dry eye medication at screening stage.
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Chiun Ho Hou, Ph.D — National Taiwan University Hospital
- Study coordinator: Chiun Ho Hou, Ph.D
- Email: chiunhohou@gmail.com
- Phone: +88623123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tropicamide/phenylephrine safety in hospitalized patients
This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.
-
Identification of Cellular Biomarkers in Rare Eye Diseases
This study tests whether specific gene and protein markers in cells and tears can distinguish adults with rare corneal diseases from others and relate to their eye symptoms.
-
Using oral anti-anxiety medication during second eye cataract surgery
This study is testing if taking the anti-anxiety medication XANAX can help people feel less anxious and more comfortable during their second eye cataract surgery compared to a placebo.
-
Improving eye surface health before cataract surgery with Systane COMPLETE
This study tests if using Systane COMPLETE can help people with dry eyes feel better before cataract surgery and improve their surgery results.
-
Traq device test of binocular eye function in people with and without a concussion
This study tests the Traq device to see how well binocular eye function works in healthy people compared with people who recently had a mild-to-moderate traumatic brain injury.
-
Neos™ virtual-reality test for measuring eye movements and pupil responses
This test uses a VR headset (neos™) to record where your eyes look and how your pupils react in healthy volunteers and people with eye or brain conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.